Utah Medical Products Inc(UTMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:48 PM ET (Korea 9/12 08:48)
Full metrics table
| Index | RUT | P/E | 21.23 | EPS (ttm) | 3.28 | Insider Own | 7.17% | Shs Outstand | 3.2M | Perf Week | -1.41% |
| Market Cap | 0.22B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 3.0M | Perf Month | -3.36% |
| Enterprise Value | 0.13B | PEG | - | EPS next Q | - | Inst Own | 73.29% | Short Float | 5.64% | Perf Quarter | 0.39% |
| Income | 0.01B | P/S | 6.15 | EPS this Y | - | Inst Trans | 2.14% | Short Ratio | 5.8 | Perf Half Y | 11.29% |
| Sales | 0.04B | P/B | 1.82 | EPS next 5Y | - | ROA | 8.55% | Short Interest | 0.17M | Perf YTD | 24.57% |
| Book/sh | 38.34 | P/C | 2.54 | EPS past 3/5Y | -8.33% 3.45% | ROE | 8.75% | 52W High | -7.97% ($75.75) | Perf Year | 11.46% |
| Cash/sh | 27.49 | P/FCF | 19.38 | Sales past 3/5Y | -9.68% -1.8% | ROIC | 8.58% | 52W Low | 29.91% ($53.66) | Perf 3Y | -19.92% |
| Dividend Est. | $1.23 (1.77%) | EV/EBITDA | 10.42 | EPS Y/Y TTM | -12.28% | Gross Margin | 53.59% | Volatility(W/M) | 2.07% 2.24% | Perf 5Y | -21.12% |
| Dividend TTM | 1.23 | EV/Sales | 3.73 | Sales Y/Y TTM | -7% | Oper. Margin | 28.97% | ATR (14) | 1.73 | Perf 10Y | 12.24% |
| Dividend Ex-Date | 2026/9/17 | Quick Ratio | 44.27 | EPS Q/Q | -10.16% | Profit Margin | 29.04% | RSI (14) | 45 | Recom | 1 |
| Dividend Gr. 3/5Y | 1.68% 1.89% | Current Ratio | 48.62 | Sales Q/Q | -14.31% | SMA20 | -1.88% ($71.05) | Beta | 0.4 | Target Price | $65.23 |
| Payout | 35.17% | Debt/Eq | 0 | Earnings | - | SMA50 | -1.09% ($70.48) | Rel Volume | 0.64 | Prev Close | $69.64 |
| Employees | 183 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 7.03% ($65.13) | Avg Volume(3M) | 0.03M | Price | $69.71 |
| IPO | 1999/3/8 | Option/Short | No/Yes | Trades | 630 | Volume | 18,375 | Change | 0.1% |
Company
UTMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 Utah Medical Products is a U.S. medical device company specializing in women's health, obstetrics and gynecology, neonatal care, and blood pressure monitoring. Leveraging more than 40 years of accumulated precision manufacturing and engineering expertise, the company supplies both its own branded devices and contract-manufactured (OEM) components in niche markets where clinical reliability is critical.
Over the past 1 year, roughly in the middle
8% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend September 17
UTMD makes money exceptionally well
28.97% of revenue is kept as operating profit.
Tap to view numbers
The stock looks undervalued
Trading at 21.2 times earnings.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -19.9% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.77% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 73.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
AIMS 0.00%
SQLV 0.00%
SCDS 0.00%
FSMD 0.00%
IWC 0.00%It ranks #4 in the industry
Based on market cap of $222M.
UTMD $222M PER 21.2
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is UTMD?
UTMD belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of UTMD?
The market cap of UTMD is approximately $222M, ranking 4,040 within its sector.
Does UTMD pay dividends?
UTMD has a dividend yield of approximately 1.77%, with an annual dividend of $1.23.
What is the P/E ratio of UTMD?
UTMD has a P/E ratio of approximately 21.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for UTMD?
UTMD has recorded a 52-week high of $75.75 and a low of $53.66.
